SNCA and Parkinson disease: However, several relevant aspects of the Parkinson’s disease phenotype are recapitulated when different forms of human α-synuclein or even C-terminally tagged versions are heterologously expressed in yeast cells (Figure 1A; [54,59,62,63,64]).